keyboard_arrow_up

MarketResearchReports.Com: Personalized Medicine Partnering Terms and Agreements, New Report Launched

Comprehensive understanding and unprecedented access tthe personalized medicine partnering deals and agreements entered intby the worlds leading healthcare companies.

The Personalized Medicine Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access tthe personalized medicine partnering deals and agreements entered intby the worlds leading healthcare companies.

The report provides a detailed understanding and analysis of how and why companies enter personalized medicine partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right tlicense the licensors personalized medicine technology. These deals tend tbe multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight intthe negotiation process in terms of what you can expect tachieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases dnot.

This report contains over 1000 links tonline copies of actual personalized medicine deals and contract documents as submitted tthe Securities Exchange Commission by companies and their partners. Contract documents provide the answers tnumerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability tderive value from the deal.

The initial chapters of this report provide an orientation of personalized medicine dealmaking and business activities. Chapter 1 provides an introduction tthe report, whilst chapter 2 provides an overview of the trends in personalized medicine dealmaking since 2009, including details of average headline, upfront, milestone and royalty terms.

Chapter 3 provides a review of the leading biomarker deals since 2009. Deals are listed by headline value, signed by big pharma and most active of all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access tthe contract.

Chapter 4 provides a review of the leading companion diagnostic deals since 2009. Deals are listed by headline value, sig ned by bigpharma and most active of all biopharma companies. Where the deal has an agreement contract published at the SEC a link provides online access tthe contract.

Chapter 5 provides a review of the leading pharmacogenomics deals since 2009. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access tthe contract.

Chapter 6 provides a comprehensive listing of the top 50 big pharma companies with a brief summary followed by a comprehensive listing of personalized medicine deals including biomarker, companion diagnostic, pharmacogenomics, as well as contract documents available in the public domain. Where available, each deal title links via Weblink tan online version of the actual contract document, providing easy access teach contract document on demand.

Chapter 7 provides a comprehensive and detailed review of biomarker partnering deals signed and announced since 2009, where a contract document is available in the public domain. The chapter is organized by stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and specific therapy focus. Each deal title links via Weblink tan online version of the deal record and where available, the contract document, providing easy access teach contract document on demand.

Chapter 8 provides a comprehensive and detailed review of companion diagnostics partnering deals signed and announced since 2009, where a contract document is available in the public domain. The chapter is organized by stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and specific therapy focus. Each deal title links via Weblink tan online version of the deal record and where available, the contract document, providing easy access teach contract document on demand.

Chapter 9 provides a comprehensive and detailed review of pharmacogenomics partnering deals signed and announced since 2009, where a contract document is available in the public domain. The chapter is organized by stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc), and specific therapy focus. Each deal title links via Weblink tan online version of the deal record and where available, the contract document, providing easy access teach contract document on demand.

Chapter 10 provides a comprehensive and detailed review of personalized medicine partnering deals signed and announced since January 2009. The chapter is organized by specific personalized medicine, biomarkers, companion diagnostics and pharmacogenomics technology type in focus. Each deal title links via Weblink tan online version of the deal record and where available, the contract document, providing easy access teach contract document on demand.

In addition, a comprehensive appendix is provided organized by personalized medicine partnering company A-Z , deal type, and therapy type. Each deal title links via Weblink tan online version of the deal record and where available, the contract document, providing easy access teach contract document on demand.

Report scope

Personalized Medicine Partnering Terms and Agreements is intended tprovide the reader with an in-depth understanding and access tpersonalized medicine trends and structure of deals entered intby leading companies worldwide.

Personalized Medicine Partnering Terms and Agreements includes:

  • Trends in personalized medicine dealmaking in the biopharma industry since 2009
  • Analysis of personalized medicine deal structure
  • Access theadline, upfront, milestone and royalty data and contract documents
  • Case studies of real-life personalized medicine deals
  • Access tover 1000 personalized medicine deal announcements
  • The leading personalized medicine deals by value since 2009
  • Most active personalized medicine dealmakers since 2007
The leading personalized medicine partnering resources In Personalized Medicine Partnering Terms and Agreements, the available contracts are listed by:

  • Company A-Z
  • Headline value
  • Stage of development at signing
  • Deal component type
  • Specific therapy target

Each deal title links via Weblink tan online version of the deal record and where available, the contract document, providing easy access teach contract document on demand.

The Personalized Medicine Partnering Terms and Agreements report provides comprehensive access tavailable deals and contract documents for over 1000 personalized medicine deals. Analyzing actual contract agreements allows assessment of the following:

  • What are the precise personalized medicine rights granted or optioned?
  • What is actually granted by the agreement tthe partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How are sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Whis responsible for commercialization?
  • Whis responsible for development, supply, and manufacture? How is confidentiality and publication managed?
  • How are disputes tbe resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear tdiffer from partner tpartner or deal type tdeal type?
  • Which jurisdiction does the company insist upon for agreement law?

Benefits

Personalized Medicine Partnering Terms and Agreements provides the reader with the following key benefits:

  • In-depth understanding of personalized medicine deal trends since 2009
  • Access theadline, upfront, milestone and royalty data
  • Analysis of the structure of personalized medicine agreements with numerous real life case studies
  • Comprehensive access tover 1000 actual personalized medicine deals entered intby the world’s biopharma companies
  • Detailed access tactual personalized medicine contracts enter intby the leading fifty bigpharma companies
  • Insight intthe terms included in a personalized medicine agreement, together with real world clause examples
  • Understand the key deal terms companies have agreed in previous deals
  • Undertake due diligence tassess suitability of your proposed deal terms for partner companies

Spanning over 1289 pages, “Personalized Medicine Partnering Terms and Agreements” report covering the Trends in personalized medicine dealmaking, Leading biomarker deals, Leading companion diagnostic deals, Leading pharmacogenomics deals, Big pharma personalized medicine deals, Biomarker contracts dealmaking directory, Companion diagnostic contracts dealmaking directory, Pharmacogenomics contracts dealmaking directory, Personalized Medicine dealmaking directory by specific technology type, Personalized medicine partnering resource center.

For more information see -  http://mrr.cm/ZQc

Find all Pharma and Healthcare Reports at: http://www.marketresearchreports.com/pharma-healthcare

About Market Research Reports, Inc.

Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

Contact Us:

Mr. Amitava Sen
Vice President - Sales & Marketing
Market Research Reports, Inc.
Tel USA: +1-302-703-7787
Tel India: +91-80-26860858

Join us for Pharma industry updated: http://www.linkedin.com/company/pharmaceuticals

For latest market research presentations visit: http://www.marketresearchdocs.com

For latest market research videos visit: http://www.marketresearch.tv